Lacosamide Torrent

Lacosamide, the active ingredient in Lacosamide Torrent, is a sodium channel blocker presented as an oral tablet for oral use. It treats partial‑onset seizures (focal seizures) associated with epilepsy in patients who require antiepileptic therapy. It is indicated for patients with focal epilepsy, either as monotherapy or as adjunctive therapy, and is formulated for convenient oral administration.

GNH USA supplies Lacosamide Torrent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU manufacturing standards and providing reliable global distribution.

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control focal seizure activity.

Partial‑onset seizures (focal seizures): reduces seizure frequency in patients with epilepsy. Adjunctive therapy for focal epilepsy: used as an add‑on when seizures persist despite other antiepileptic drugs. Monotherapy for focal epilepsy: may be prescribed as initial treatment in patients newly diagnosed with focal seizures.

Lacosamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue - Diplopia (double vision)

Serious or Rare Side Effects: - Suicidal thoughts or behavior - Severe skin reactions such as Stevens‑Johnson syndrome - Cardiac arrhythmias, including atrial fibrillation - Severe allergic reactions (anaphylaxis)

When prescribing Lacosamide, clinicians should consider several safety factors.

Renal impairment: dose may need adjustment and renal function should be monitored. Hepatic impairment: monitor liver enzymes and consider dose modification. Cardiac conduction disorders: use with caution; ECG monitoring recommended. Pregnancy: potential risks unknown; prescribe only if benefits outweigh risks. Concomitant antiepileptic drugs: monitor for altered efficacy or toxicity. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Lacosamide can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: induces metabolism and may lower lacosamide plasma levels. - Phenytoin: induces metabolism and may reduce lacosamide exposure. - Strong CYP2C19 inhibitors (e.g., fluconazole): increase lacosamide concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs (e.g., valproate): may require efficacy monitoring.